| Кальция карбонат | 471-34-1 | CCaO3 | L-лизин, N- (1-оксогексадецил) глицил-L-гистидил- | 147732-56-7 | C30H54N6O5 | Пасиреотид | 396091-73-9 | C58H66N10O9 | Octreotide | 79517-01-4 | C51H70N10O12S2 | Глицил-L-гистидил-L-лизин | 49557-75-7 | C14H24N6O4 | Анти-NT-ProBNP | 124584-08-3 | C143H244N50O42S4 | GLP-1(7-37) | 106612-94-6 | C151H228N40O47 | Human GLP-1 (7-36)-NH2 | 107444-51-9 | C149H226N40O45 | Трипторелин | 57773-63-4 | C64H82N18O13 | CNV-38d(1-34) | 52232-67-4 | C172H278N52O47S2 | Thymosin alpha 1 | 62304-98-7 | C129H215N33O55 | Antide | 112568-12-4 | C82H108ClN17O14 | Энфувиртид | 159519-65-0 | C204H301N51O64 | GLP-2, human | 99120-49-7 | C171H266N48O56S1 | Leuprorelin | 74381-53-6 | C61H88N16O14 | Глюкагон | 16941-32-5 | C153H225N43O49S | Katacalcin | 85916-47-8 | C97H154N34O36S2 | АДРЕНОМЕДУЛЛИН (ЧЕЛОВЕЧЕСКИЙ) | 148498-78-6 | C264H406N80O77S3 | Amyloid β-Protein(16-22) | 153247-41-7 | C43H64N8O10 | Ganirelix | 123246-29-7 | C80H113ClN18O13 | Angiotensin Converting Enzyme Inhibitor | 35115-60-7 | C53H76N14O12 | Н-His-ASP-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-VAL-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala- ALA-Lys-Glu-Phe-Ile-ALA-TRP-Leu-Val-Lys-Gly-Arg-NH2 | 99658-04-5 | C184H273N51O57 | Exenatide acetate | 141732-76-5 | C186H286N50O62S | (S)-6-[3-(4-Boc-1-piperazinyl)propoxy]-N-[2-(2-cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide | 2374782-82-6 | C29H36F2N6O5 | Oligonucleotide Synthesis | 4097-22-7 | C10H13N5O2 | Peptide customization | | | Peptide synthesis service | | | Fmoc-Ala-Thr[PSI(Me,Me)Pro]-OH | 252554-79-3 | C25H28N2O6 | Fmoc-Val-Thr[PSI(Me,Me)Pro]-OH | 168216-05-5 | C27H32N2O6 | Fmoc-Ile-Thr[PSI(Me,Me)Pro]-OH | 957780-52-8 | C28H34N2O6 | Fmoc-Phe-Thr[PSI(Me,Me)Pro]-OH | 1196703-48-6 | C31H32N2O6 | 1,4,7,10-Тетраазациклододекан-1,4,7,10-тетрауксусная кислота, 2-[(4-изотиоцианатофенил)метил]- | 127985-74-4 | C24H33N5O8S | NOTAGA-tris(t-Buester) | 438553-50-3 | | Fmoc-Asn(Trt)-Ser[PSI(Me,Me)Pro]-OH | 920519-33-1 | C44H41N3O7 | FMOC-АЛК-Ser (YME, MEPRO) -OH | 252554-78-2 | C24H26N2O6 | FMOC-ВАЛ-СЕР(PSIME,MEPRO)-ОН | 186023-49-4 | C26H30N2O6 | Fmoc-Thr(tBu)-Ser(Psi(Me,Me)pro)-OH | 1425938-63-1 | C29H36N2O7 | Fmoc-Gly-Ser[PSI(Me,Me)Pro]-OH | 1095952-22-9 | C23H24N2O6 | Fmoc-Leu-Thr[PSI(Me,Me)Pro]-OH | 955048-89-2 | C28H34N2O6 | NOTA-bis(t-Buester) | 1161415-28-6 | C20H37N3O6 | 2'-OMe-Bz-C-CE-Phosphoramidite; N4-benzoyl-5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-Cytidine-3'-CE-Phosphoramidite | 110764-78-8 | C47H54N5O9P | 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 150780-67-9 | C45H56N7O9P | 2'-О-метил-гА (N-Bz) фосфорамидит | 110782-31-5 | C48H54N7O8P | 5'-O-(4,4-Dimethoxytrityl)-2'-O-methyluridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 110764-79-9 | C40H49N4O9P | N4-бензоил-2'-дезокси-5'-O-DMT-2'-фторцитидин фосфорамидит | 161442-19-9 | C46H51FN5O8P | 2'-F-Bz-dA-CE-Phosphoramidite; 2'-fluoro-N6-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine-3'-CE-Phosphoramidite | 136834-22-5 | C47H51FN7O7P | 2'-F-iBu-dG-CE-Phosphoramidite; 2'-fluoro-N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine-3'-CE-Phosphoramidite | 144089-97-4 | C44H53FN7O8P | Morpholino A subunit; (6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl) methyl dimethylphosphoramidochloridate | 956139-18-7 | C38H37ClN7O4P | Morpholino C subunit; 6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl Dimethylphosphoramidochloridate | 956139-21-2 | C37H37ClN5O5P | Morpholino T subunit; 6-(5-methyl-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)-4-ritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate | 956139-30-3 | C31H34ClN4O5P | Morpholino U subunit | | | Fmoc-Tyr(tBu)-Ser[PSI(Me,Me)Pro]-OH | 878797-09-2 | C34H38N2O7 | Fmoc-Lys(Boc)-Ser[PSI(Me,Me)Pro]-OH | 957780-54-0 | C32H41N3O8 | Fmoc-Leu-Ser[PSI(Me,Me)Pro]-OH | 339531-50-9 | C27H32N2O6 | Fmoc-Ile-Ser[PSI(Me,Me)Pro]-OH | 1147996-34-6 | C27H32N2O6 | Maleimido-mono-amide-NOTA | 1295584-83-6 | C18H27N5O7 | 4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- | 2471983-20-5 | C24H28F2N6O3 | Ангиотензин II (человека) | 4474-91-3 | C50H71N13O12 | Окситоцин | 50-56-6 | C43H66N12O12S2 | Эптифибатид | 188627-80-7 | C35H49N11O9S2 | ЦИКЛО (ARG-GLY-ASP-D-PHE-LYS) | 161552-03-0 | C27H41N9O7 | Icatibant | 30308-48-4 | C59H89N19O13S | polypeptide | | | H2N-Gly-Pro-Ser(tBu)-S(tBu)-Gly-Ala-Pro-Pro-Pro-S(tBu)-CONH2 | | | BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly | | | Fmoc-Asp(OtBu)-Lys(Boc)-Ile-Ala-Gln(Trt)-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-Ala | | | Fmoc-Trp(Boc)-Thr[PSI(Me,Me)Pro]-OH | 936707-21-0 | C38H41N3O8 | Pramlintide acetate | 196078-30-5 | C173H273N51O56S2 | (2S) -бета-аланил-L-пролил-2,4-диамино-N- (фенилметил) бутанамид ацетат | 823202-99-9 | C19H29N5O3.2(C2H4O2) | Myristoyl-Hexapeptide-16 | 959610-54-9 | C47H91N9O8 | N2-ацетил-L-лизилглицил-L-гистидил-L-лизинамид | 827306-88-7 | C22H39N9O5 | Palmitoyl Pentapeptide-4 | 214047-00-4 | C39H75N7O10 | Myristoyl Pentapeptide-17 | 959610-30-1 | C41H81N9O6 | N-ацетил-бета-аланин-L-гистидил-L-серил-L-гистидин | 820959-17-9 | C20H28N8O7 | ПАЛЬМИТОИЛ ТЕТРАПЕПТИД 3 | 221227-05-0 | C34H62N8O7 | Трипептид биотинил-GHK | 299157-54-3 | C24H38N8O6S | Myristoyl Tetrapeptide-12 | 959610-24-3 | C32H63N7O5 | Лейпрорелин | 53714-56-0 | C59H84N16O12 | Гозерелин | 65807-02-5 | C59H84N18O14 | Glucagon HCL | 11140-85-5 | C6H9ClO5 | Ziconotide acetate | 107452-89-1 | C102H172N36O32S7 | 2'-F-dU-CE-Phosphoramidite | | | Fmoc-Asp(tBu)-Thr[PSI(Me,Me)Pro]-OH | 920519-32-0 | C30H36N2O8 | Fmoc-Tyr(tBu)-Thr[PSI(Me,Me)Pro]-OH | 920519-31-9 | C35H40N2O7 | FMOC-PHE-SER(PSIME,MEPRO)-ОН | 878797-01-4 | C30H30N2O6 | Morpholino G subunit | | | Maleimido-mono-amide-DOTA | 1006711-90-5 | C22H34N6O9 | DOTA-моно-NHS-трис (эфир t-Bu) (B-270) | 819869-77-7 | C32H55N5O10 | DOTAGA-tetra(tBuester) | 306776-79-4 | C35H64N4O10 | DOTA-NHS-ester | 1823122-52-6 | C22H33F9N5O12P | DOTAM-mono-acid | 913528-04-8 | C16H31N7O5 | Тирзепатид | 2023788-19-2 | | ТРИ-ТЕРТ-БУТИЛ 1 4 7 10-ТЕТРААЗАЦИКЛОДОД | 137076-54-1 | C28H52N4O8 | BocNH-Tyr(tBu)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Tyr(tBu)-Ser(tBu)-Ile-Aib-Leu | | | Fmoc-Phe-Val-Gln(Trt)-Trp(Boc)-Leu-Ile-Ala-Gly | | | Peptide fluorescent modification | | | Custom Peptide | | | DOTAM-NHS-ester | 2236057-47-7 | C20H34N8O7 | Fmoc-Gln(Trt)-Ser[PSI(Me,Me)Pro]-OH | 1821378-64-6 | C45H43N3O7 | Oligonucleotide customization | | | Fmoc-Gln(Trt)-Thr(Psi(Me,Me)pro)-OH | 1572725-72-4 | C46H45N3O7 |